Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about PTN: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
PTN is a concept in neurodegeneration research. Key relationships include: expressed in, interacts with, implicated in. Associated with AD, ALI, ALS. Connected to 74 entities in the SciDEX knowledge graph.
AI-generated illustration · click image to enlarge
Regenerate portrait ↻| Name | PTN |
| Key Genes/Proteins | AKT, ALZHEIMER, AMYLOID |
| Related Diseases | AD, ALI, Als, ALS, Alzheimer |
| Related Pathways | Akt, Amyloid |
| Linked Hypotheses | 4 hypotheses |
Knowledge base pages for this entity
graph TD
PTN["PTN"]
PTN -->|"interacts"| PTPRZ1["PTPRZ1"]
PTN -->|"activates"| adult_hippocampal_neurogenesis["adult hippocampal neurogenesis"]
PTN -.protects against.-> cognitive_impairment["cognitive impairment"]
PTN -.protects against.-> memory_deficits["memory deficits"]
PTN -->|"activates"| memory["memory"]
PTN -.biomarker for.-> Alzheimer["Alzheimer"]
PTN -->|"expressed in"| ALS["ALS"]
PTN -.biomarker for.-> Amyloid["Amyloid"]
PTN -->|"interacts"| AMYLOID["AMYLOID"]
PTN -->|"expressed in"| ALZHEIMER_S_DISEASE["ALZHEIMER'S DISEASE"]
PTN -->|"expressed in"| JUN["JUN"]
aging["aging"] -->|"regulates"| PTN
AMYLOID -.biomarker for.-> PTN
ALZHEIMER_S_DISEASE -.biomarker for.-> PTN
ALZHEIMER["ALZHEIMER"] -.biomarker for.-> PTN
COMPLEMENT["COMPLEMENT"] -->|"expressed in"| PTN
NTN1["NTN1"] -->|"interacts"| PTN
TARDBP["TARDBP"] -->|"interacts"| PTN
SNRNP70["SNRNP70"] -->|"interacts"| PTN
AND["AND"] -->|"interacts"| PTN| Target | Relation | Type | Str |
|---|---|---|---|
| Alzheimer'S Disease | associated_with | disease | 0.85 |
| ALZHEIMER'S DISEASE | associated_with | entity | 0.80 |
| cognitive impairment | protects_against | disease | 0.70 |
| memory deficits | protects_against | process | 0.70 |
| memory | activates | process | 0.70 |
| adult hippocampal neurogenesis | activates | process | 0.70 |
| PTPRZ1 | interacts_with | protein | 0.70 |
| Alzheimer | biomarker_for | disease | 0.65 |
| ALS | expressed_in | disease | 0.65 |
| Alzheimer | expressed_in | disease | 0.65 |
| Depression | activates | disease | 0.65 |
| Ms | biomarker_for | disease | 0.65 |
| Als | expressed_in | disease | 0.65 |
| Cancer | expressed_in | disease | 0.65 |
| Parkinson | expressed_in | disease | 0.65 |
| Carcinoma | expressed_in | disease | 0.65 |
| Neurodegeneration | expressed_in | disease | 0.65 |
| CD4 | expressed_in | gene | 0.60 |
| ALZHEIMER'S DISEASE | biomarker_for | gene | 0.60 |
| VGF | associated_with | gene | 0.60 |
| RNA | expressed_in | gene | 0.60 |
| TAR | interacts_with | gene | 0.60 |
| Microrna | expressed_in | pathway | 0.60 |
| AND | inhibits | gene | 0.60 |
| CANCER | expressed_in | gene | 0.60 |
| GENES | expressed_in | gene | 0.60 |
| CD8 | expressed_in | gene | 0.60 |
| DNA | interacts_with | gene | 0.60 |
| NTN1 | interacts_with | gene | 0.60 |
| VGF | interacts_with | gene | 0.60 |
| SNRNP70 | interacts_with | gene | 0.60 |
| TARDBP | interacts_with | gene | 0.60 |
| TAU | interacts_with | gene | 0.60 |
| NTN3 | interacts_with | gene | 0.60 |
| Protein Aggregation | expressed_in | pathway | 0.60 |
| Amyloid | interacts_with | pathway | 0.60 |
| Endocytosis | expressed_in | pathway | 0.60 |
| Exocytosis | expressed_in | pathway | 0.60 |
| Complement | expressed_in | pathway | 0.60 |
| GPNMB | associated_with | gene | 0.60 |
| AMYLOID | biomarker_for | gene | 0.60 |
| COMPLEMENT | expressed_in | gene | 0.60 |
| PTPRZ1 | inhibits | gene | 0.60 |
| Akt | therapeutic_target | pathway | 0.60 |
| ALZHEIMER | expressed_in | gene | 0.60 |
| cancer | associated_with | disease | 0.60 |
| apoptosis pathway | participates_in | pathway | 0.60 |
| STAT3 | inhibits | gene | 0.60 |
| STAT3 | activates | gene | 0.60 |
| Amyloid | biomarker_for | pathway | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| aging | regulates | process | 0.70 |
| GPNMB | interacts_with | gene | 0.60 |
| NPTX2 | interacts_with | gene | 0.60 |
| GPNMB | associated_with | gene | 0.60 |
| AMYLOID | biomarker_for | gene | 0.60 |
| ALZHEIMER'S DISEASE | biomarker_for | gene | 0.60 |
| VGF | associated_with | gene | 0.60 |
| NTN1 | associated_with | gene | 0.60 |
| ALZHEIMER | biomarker_for | gene | 0.60 |
| NPTX2 | associated_with | gene | 0.60 |
| COMPLEMENT | expressed_in | gene | 0.60 |
| ALZHEIMER'S DISEASE | expressed_in | gene | 0.60 |
| ALZHEIMER | expressed_in | gene | 0.60 |
| NTN1 | interacts_with | gene | 0.60 |
| TARDBP | interacts_with | gene | 0.60 |
| TAU | interacts_with | gene | 0.60 |
| SNRNP70 | interacts_with | gene | 0.60 |
| NEURODEGENERATION | expressed_in | gene | 0.60 |
| PARKINSON'S DISEASE | expressed_in | gene | 0.60 |
| ROBO1 | expressed_in | gene | 0.60 |
| PARKINSON | expressed_in | gene | 0.60 |
| NEURODEGENERATIVE DISEASES | expressed_in | gene | 0.60 |
| CSF1 | activates | gene | 0.60 |
| CSF1R | activates | gene | 0.60 |
| FGF1 | activates | gene | 0.60 |
| FGFR2 | activates | gene | 0.60 |
| DNA | interacts_with | gene | 0.60 |
| RNA | expressed_in | gene | 0.60 |
| JUN | expressed_in | gene | 0.60 |
| AMYLOID | interacts_with | gene | 0.60 |
| NTN3 | interacts_with | gene | 0.60 |
| AKT | activates | gene | 0.60 |
| APP | expressed_in | gene | 0.60 |
| PS1 | expressed_in | gene | 0.60 |
| JNK | activates | gene | 0.60 |
| MAPK | activates | gene | 0.60 |
| PTPRZ1 | inhibits | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| TBK1-OPTN-NDP52 Phospho-Cascade Coordinates Multi-Organelle | 0.772 | neurodegeneration | How do different organelle-specific auto |
| OPTN/TBK1 mutations create selective vulnerability by blocki | 0.670 | neurodegeneration | What are the neuron-specific effects of |
| ALS-Linked OPTN/TBK1 Mutations Impair Phosphorylation Cascad | 0.648 | neurodegeneration | How do pathological stress granules in n |
| TREM2 Agonism to Redirect Microglia from Synaptic Pruning to | 0.521 | neurodegeneration | How do ALS-associated OPTN mutations mec |
| Loss of pericyte-derived pleiotrophin is a key disease-modif | 0.510 | neurodegeneration | Does pericyte senescence drive BBB break |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-14 | 1 hypotheses Top: 0.521
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810] | ["Chen Kai", "Li Fuyao", "Zhang Shuwen", | Journal of neuroinflammation | 2025 | 0 |
| Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810] | ["Chen Kai", "Li Fuyao", "Zhang Shuwen", | Journal of neuroinflammation | 2025 | 0 |
| Neurodegeneration and Inflammation-An Interesting Interplay in Parkinson's Disea [PMID:33182554] | Marogianni C, Sokratous M, Dardiotis E, | International journal of molec | 2020 | 0 |
| Neurodegeneration and Inflammation-An Interesting Interplay in Parkinson's Disea [PMID:33182554] | Marogianni C, Sokratous M, Dardiotis E, | International journal of molec | 2020 | 0 |
| DNA Damage, Neurodegeneration, and Synaptic Plasticity. [PMID:27313899] | Merlo, Cuchillo-Ibañez, Parlato, Ra | Neural plasticity | 2018 | 0 |
| Multiple Sclerosis Pathology. [PMID:29358320] | Lassmann H | Cold Spring Harbor perspective | 2018 | 0 |
| DNA Damage, Neurodegeneration, and Synaptic Plasticity. [PMID:27313899] | Unknown | Neural Plast | 2016 | 0 |
| Neurodegeneration. [PMID:12938729] | Burgunder | IUBMB life | 2004 | 0 |
| Neurodegeneration. [PMID:12938729] | Unknown | IUBMB Life | 2003 | 0 |
Multi-agent debates referencing this entity
Hypotheses and analyses mentioning PTN in their description or question text
No additional research found